Higher TSH and lower T3 levels are linked to an increased risk for major liver outcomes and major cardiovascular events among those with MASLD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results